A single luteinizing hormone determination 2 hours after depot leuprolide is useful for therapy monitoring of gonadotropin-dependent precocious puberty in girls

Journal of Clinical Endocrinology and Metabolism

Volumn 89, Issue 9, 2004, Pages 4338-4342

  Brito, Vinicius N ^a   Latronico, Ana C ^a   Arnhold, Ivo J P ^a   Mendonca, Berenice B ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

GONADORELIN; GONADORELIN DERIVATIVE; GONADOTROPIN; LEUPRORELIN; LUTEINIZING HORMONE;

ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; GONADORELIN TEST; HORMONE DETERMINATION; HUMAN; HYPOTHALAMUS HYPOPHYSIS GONAD SYSTEM; INTERMETHOD COMPARISON; LUTEINIZING HORMONE BLOOD LEVEL; PRECOCIOUS PUBERTY; PREPUBERTY; PRIORITY JOURNAL;

CHILD; CHILD, PRESCHOOL; FEMALE; GONADOTROPIN-RELEASING HORMONE; HUMANS; INFANT; LEUPROLIDE; LUTEINIZING HORMONE; PUBERTY, PRECOCIOUS; TIME FACTORS;

EID: 4544293563     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2003-031537     Document Type: Article

References (18)

1. Toguchi H 1990 Pharmaceutical manipulation of leuprorelin acetate to improve clinical performance. J Int Med Res 18(Suppl 1):35-41
2. Parker KL, Baens-Bailon RG, Lee PA 1991 Depot leuprolide acetate dosage for sexual precocity. J Clin Endocrinol Metab 73:50-52
3. Manasco PK, Pescovitz OH, Hill SC, Jones JM, Barnes KM, Hench KD, Loriaux DL, Cutler Jr GB 1989 Six year results of luteinizing hormone releasing (LHRH) agonist treatment in children with LHRH-dependent precocious puberty. J Pediatr 114:321-324
4. Witchel SF, Baens-Bailon RG, Lee PA 1996 Treatment of central precocious puberty: comparison of urinary gonadotropin excretion and gonadotropin-releasing hormone (GnRH) stimulation tests in monitoring GnRH analog therapy. J Clin Endocrinol Metab 81:1353-1356
5. Cavallo A, Richards E, Busey S, Michaels SE 1995 A simplified gonadotrophin-releasing hormone test for precocious puberty. Clin Endocrinol (Oxf) 42:641-646
6. Bhatia S, Neely EK, Wilson DM 2002 Serum luteinizing hormone rises within minutes after depot leuprolide injection: implications for monitoring therapy. Pediatrics 109:E30
7. Lahlou N, Carel JC, Chaussain JL, Roger M 2000 Pharmacokinetics and pharmacodynamics of GnRH agonists: clinical implications in pediatrics. J Pediatr Endocrinol Metab 13:723-737
8. Brito VN, Batista MC, Borges MF, Latronico AC, Kohek MBF, Thirone ACP, Jorge BH, Arnhold IJP, Mendonca BB 1999 Diagnostic value of fluorometric assays in the evaluation of precocious puberty. J Clin Endocrinol Metab 84:3539-3544
9. Greulich WW, Pyle SI 1959 Radiographic atlas of skeletal development of the hand and wrist. Stanford: Stanford University Press
10. Lee PA 1994 Laboratory monitoring of children with precocious puberty. Arch Pediatr Adolesc Med 148:369-376
11. Carel JC, Lahlou N, Guazzarotti L, Joubert-Collin M, Roger M, Colle M, Chaussain IL 1995 Treatment of central precocious puberty with depot leuprolide acetate. Eur J Endocrinol 132:699-704
12. Carel JC, Lahlou N, Jaramillo O, Montauban V, Teinturier C, Colle M, Lucas C, French Leuprorelin Trial Group, Chaussain JL 2002 Treatment of central precocious puberty by subcutaneous injections of leuprorelin 3-month depot (11.25 mg). J Clin Endocrinol Metab 87:4111-4116
13. Lawson ML, Cohen N 1999 A single sample subcutaneous luteinizing hormone (LH)-releasing hormone (LHRH) stimulation test for monitoring LH suppression in children with central precocious puberty receiving LHRH agonists. J Clin Endocrinol Metab 84:4536-4540
14. Cook JS, Doty KL, Conn PM, Hansen JR 1992 Assesment of depot Lupron dose-adequacy for central precocious puberty. J Clin Endocrinol Metab 74:1206-1209
15. Salerno M, Di Maio S, Gasparini N, Mariano A, Macchia V, Tenore A 1998 Central precocious puberty: a single blood sample after gonadotropin-releasing hormone agonist administration in monitoring treatment. Horm Res 50:4:205-211
16. Neely EK, Wilson DM, Bachrach LK 1993 Efficacy of depot leuprolide acetate in the treatment of central precocious puberty. Pediatr Res 29(Suppl):83A
17. Antoniazzi F, Cisternino M, Nizzoli G, Bozzola M, Comas A, De Luca F, De Sanctis C, Rigon F, Zamboni G, Bernasconi S 1994 Final height in girls with central precocious puberty: comparison of two different luteinizing hormone-releasing hormone agonist treatments. Acta Paediatr 83:1052-1056
18. Kappy MS, Stuart T, Perelman 1988 Efficacy of leuprolide therapy in children with central precocious puberty. Am J Dis Child 142:1061-1064